Teladoc Health
TDOC
436 hedge funds and large institutions have $2.33B invested in Teladoc Health in 2023 Q3 according to their latest regulatory filings, with 63 funds opening new positions, 140 increasing their positions, 122 reducing their positions, and 53 closing their positions.
58% more call options, than puts
Call options by funds: $145M | Put options by funds: $91.6M
19% more first-time investments, than exits
New positions opened: 63 | Existing positions closed: 53
15% more repeat investments, than reductions
Existing positions increased: 140 | Existing positions reduced: 122
1% more funds holding
Funds holding: 431 → 436 (+5)
3.71% less ownership
Funds ownership: 78.81% → 75.1% (-3.7%)
29% less capital invested
Capital invested by funds: $3.27B → $2.33B (-$939M)
50% less funds holding in top 10
Funds holding in top 10: 4 → 2 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$28.5M |
| 2 |
Millennium Management
New York
|
+$19.7M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$13.3M |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$12.1M |
| 5 |
Charles Schwab
San Francisco,
California
|
+$9.78M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
-$38.6M |
| 2 |
Man Group
London,
United Kingdom
|
-$35.6M |
| 3 |
Two Sigma Advisers
New York
|
-$31.2M |
| 4 |
Voloridge Investment Management
Jupiter,
Florida
|
-$28.5M |
| 5 |
HRCM
Hood River Capital Management
Palm Beach Gardens,
Florida
|
-$24.4M |
TDOC Hedge Fund Activity: Q3 2023 in Review
436 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Teladoc Health (TDOC) for Q3 2023, worth a combined $2.33B — down 29% from $3.27B a quarter earlier.
Buyers outnumbered sellers: 63 funds opened new TDOC positions and 53 closed out — a net gain of 10 holders — while 140 added to existing stakes and 122 trimmed.
The largest buyer was BlackRock, adding an estimated $28.5M. The largest seller was Vanguard Group, cutting an estimated $38.6M.
- 436 institutional investors held Teladoc Health (TDOC) as of Q3 2023, up from 431 in Q2 2023.
- Funds reported $2.33B of Teladoc Health stock for Q3 2023, down 29% quarter-over-quarter.
- 63 funds opened new Teladoc Health positions in Q3 2023 and 53 closed out, a net change of +10 holders.
- The largest Teladoc Health buyer in Q3 2023 was BlackRock, an estimated $28.5M added.
- The largest Teladoc Health seller in Q3 2023 was Vanguard Group, an estimated $38.6M sold.
Based on aggregated 13F filings for Q3 2023.